CYTOKINETICS INC — Director's Dealing 2023

Mar 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-03-06

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-06	Common Stock	A	82500	—	Acquired	441058	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-06	Incentive Stock Option (Right to Buy)	$39.13	A	2555	Acquired	2033-03-06	Common Stock (2555)	Direct
2023-03-06	Non-Qualified Stock Option (Right to Buy)	$39.13	A	162445	Acquired	2033-03-06	Common Stock (162445)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.

F4: This option shall vest and become exercisable over 4-years, with vesting divided into equal monthly installments commencing on April 6, 2023 and the final monthly installment vesting on April 6, 2027.